| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,148 |
5,436 |
$263K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,840 |
9,535 |
$263K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,956 |
3,600 |
$200K |
| 84443 |
Thyroid stimulating hormone (TSH) |
11,585 |
10,439 |
$195K |
| 80061 |
Lipid panel |
13,929 |
12,512 |
$184K |
| 80053 |
Comprehensive metabolic panel |
14,417 |
12,719 |
$151K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,787 |
16,360 |
$126K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,470 |
3,008 |
$91K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,439 |
6,613 |
$70K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,867 |
2,070 |
$54K |
| 82274 |
|
3,533 |
3,309 |
$44K |
| 86328 |
|
1,597 |
1,509 |
$33K |
| 82607 |
|
2,298 |
1,918 |
$31K |
| 86738 |
|
2,510 |
2,302 |
$31K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
570 |
543 |
$29K |
| 84153 |
|
1,836 |
1,679 |
$29K |
| 86702 |
|
2,493 |
2,224 |
$28K |
| 81000 |
|
7,678 |
6,427 |
$28K |
| 84439 |
|
3,387 |
2,946 |
$28K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
846 |
724 |
$27K |
| 86701 |
|
2,908 |
2,644 |
$24K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
745 |
630 |
$24K |
| 82043 |
|
4,534 |
4,051 |
$23K |
| 36415 |
Collection of venous blood by venipuncture |
8,000 |
6,107 |
$23K |
| 81001 |
|
6,507 |
6,223 |
$17K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,936 |
1,719 |
$15K |
| 87088 |
|
1,694 |
1,472 |
$14K |
| 84436 |
|
2,030 |
1,859 |
$12K |
| 86592 |
|
2,841 |
2,577 |
$11K |
| 84479 |
|
1,534 |
1,388 |
$9K |
| 80074 |
|
140 |
128 |
$6K |
| 87400 |
|
246 |
241 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
688 |
648 |
$5K |
| 85027 |
|
877 |
723 |
$5K |
| 82570 |
|
882 |
709 |
$4K |
| 85730 |
|
848 |
740 |
$4K |
| 85610 |
|
1,223 |
1,058 |
$4K |
| 86769 |
|
97 |
95 |
$3K |
| 85651 |
|
1,072 |
958 |
$3K |
| 87899 |
|
270 |
246 |
$3K |
| 86703 |
|
301 |
280 |
$3K |
| 86706 |
|
203 |
176 |
$2K |
| 82947 |
|
612 |
562 |
$2K |
| 86038 |
|
123 |
119 |
$1K |
| 86704 |
|
99 |
87 |
$1K |
| 87084 |
|
45 |
29 |
$1K |
| 86708 |
|
95 |
93 |
$1K |
| 83540 |
|
159 |
69 |
$1K |
| 82951 |
|
80 |
80 |
$928.61 |
| 86803 |
|
67 |
42 |
$922.72 |
| 86140 |
|
202 |
191 |
$825.93 |
| 84156 |
|
274 |
261 |
$617.41 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
279 |
261 |
$589.51 |
| 87490 |
|
31 |
25 |
$573.31 |
| 84460 |
|
199 |
193 |
$479.87 |
| 84450 |
|
199 |
193 |
$462.78 |
| 82952 |
|
80 |
80 |
$444.41 |
| 82728 |
|
30 |
28 |
$386.27 |
| 87081 |
|
44 |
28 |
$290.05 |
| 87186 |
|
38 |
25 |
$242.54 |
| 83001 |
|
13 |
13 |
$205.68 |
| 87077 |
|
25 |
12 |
$200.48 |
| 82575 |
|
17 |
15 |
$149.66 |
| 84550 |
|
45 |
41 |
$139.01 |
| 83655 |
|
12 |
12 |
$136.92 |
| 85652 |
|
39 |
39 |
$96.29 |
| 81050 |
|
61 |
51 |
$86.48 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
65 |
62 |
$83.48 |
| 82565 |
|
48 |
47 |
$80.39 |
| 84520 |
|
45 |
44 |
$58.09 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
737 |
665 |
$0.86 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
870 |
674 |
$0.00 |